Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Renovorx Inc Is A Clinical-Stage Biopharmaceutical Company Developing Proprietary Targeted Combination Therapies For High Unmet Medical Needs With A Goal To Improve Therapeutic Outcomes For Cancer Patients Undergoing Treatment. Renovorx'S Patented Trans-Arterial Micro-Perfusion Therapy Platform Is Designed For Targeted Therapeutic Delivery Across The Arterial Wall Near The Tumor Site (Known As Intra-Arterial, Or Ia Delivery) To Bathe The Target Tumor, While Potentially Minimizing A Therapy'S Toxicities Versus Systemic Intravenous Therapy.